PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Radiation Oncology, London Health Sciences Centre, Canada; Department of Oncology, Western University, London, Canada. Electronic address: lucas.mendez@lhsc.on.ca.\', \'Department of Radiation Oncology, BC Cancer, Surrey, Canada.\', \'Sunnybrook Health Sciences Centre, Toronto, Canada.\', \'Division of Radiation Oncology, London Health Sciences Centre, Canada; Department of Oncology, Western University, London, Canada.\', \'University of Toronto, Department of Radiation Oncology, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0167-8140(20)30288-710.1016/j.radonc.2020.05.032
?:hasPublicationType
?:journal
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
is ?:pmid of
?:pmid
?:pmid
  • 32474128
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all